Platform
Removing fundamental barriers to unlock small molecule drug discovery
We are tackling one of the fundamental bottlenecks in small molecule drug discovery: limited access to relevant chemical space. Our proprietary platform, chemSEEK, combines artificial intelligence and cutting-edge computational methods to reimagine how small molecules are designed and discovered.
Our target-first approach maps the pharmacological needs of a target into novel chemical space. By exploring untapped areas of chemistry, we design novel and diverse small molecules with unprecedented properties – breaking down the barriers of inaccessibility for the drug, the target, and the patient.
Biology defines the challenge, chemSEEK™ designs the small molecule solution to treat it
UNLOCKING THE RIGHT CHEMICAL SPACE
Decoding the pharmacological needs of targets to identify druggable regions otherwise missed
DESIGNING THE RIGHT CHEMISTRY
Leveraging our proprietary coded data to create novel, target-tailored and diverse molecules
FINDING THE RIGHT MOLECULES
Using modular AI-driven workflows to explore multiple hypotheses in parallel, dramatically increasing the probabilty of success
Shaping the future of drug discovery together
We are open to discovery partherships to develop medicines against inacessible targets across disease areas.
We would be delighted to work with you.
